Outset Medical

OM
4.0551.12% ( +0.045 )
Trading: Oct 13, 12:50:49 (EDT)

Current ValuationThe current P/E ratio is -1.01, within the reasonable range, cheaper than 48.98% of the time in the past 3 years, and the industry ranks 82/173, the industry Median -0.92.

-1.01xP/E
Stock price$4.01Earnings per share$-3.95

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
013263952

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
BAXUSBaxter
-12.05x141.71%$12.81B
GKOSUSGlaukos
-52.70x75.37%$9.91B
TFXUSTeleflex
-5.16x118.39%$5.33B
PLSEUSPulse Biosciences
-46.73x27.55%$3.74B
IRTCUSIRhythm
-252.13x70.88%$3.52B
BFLYUSButterfly Network
-30.42x31.45%$2.28B
AXGNUSAxogen
-64.90x16.18%$2.18B
ASSTUSStrive
-1.96x63.23%$1.92B
ATECUSAlphatec
-15.80x41.67%$1.74B
NVCRUSNovocure
-11.54x1.23%$1.71B
KMTSUSKestra Medical Tech
-10.52x0.94%$1.58B
DRTSUSAlpha Tau Medical
-14.22x--$1.32B
TNDMUSTandem Diabetes
-18.08x77.60%$1.14B
PRCTUSPROCEPT BioRobotics
-10.21x3.47%$1.12B
IARTUSIntegra LifeSciences
-150.24x109.42%$1.09B
AORTUSArtivion
-332.94x266.67%$1.06B
ENOVUSEnovis
-0.96x100.97%$1.05B
CBLLUSCeribell
-14.69x35.15%$969.43M
BBNXUSBeta Bionics
-12.88x11.45%$940.18M
QDELUSQuidelOrtho
-0.87x75.33%$908.62M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.